Erenumab for Idiosyncratic Facial Pain

Clinical trial NCT04249427 · COMPLETED

Trial details

NCT number: NCT04249427
Sponsor: David Jang, M.D.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Facial Pain Rhinosinusitis

Start date: 2021-02-10
Primary completion: 2023-07-11
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.